164 related articles for article (PubMed ID: 2996746)
41. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Hawkins DS; Chi YY; Anderson JR; Tian J; Arndt CAS; Bomgaars L; Donaldson SS; Hayes-Jordan A; Mascarenhas L; McCarville MB; McCune JS; McCowage G; Million L; Morris CD; Parham DM; Rodeberg DA; Rudzinski ER; Shnorhavorian M; Spunt SL; Skapek SX; Teot LA; Wolden S; Yock TI; Meyer WH
J Clin Oncol; 2018 Sep; 36(27):2770-2777. PubMed ID: 30091945
[TBL] [Abstract][Full Text] [Related]
42. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Hong W; Zhang R; Liu L
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
[TBL] [Abstract][Full Text] [Related]
44. Nondysgerminomatous tumors of the ovary treated with cisplatin, vinblastine, and bleomycin: long-term results.
De Palo G; Zambetti M; Pilotti S; Rottoli L; Spatti G; Fontanelli R; Musumeci R; Kenda R; Bombardieri E; Stefanon B
Gynecol Oncol; 1992 Nov; 47(2):239-46. PubMed ID: 1281804
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic efficacy of cytotoxic combination chemotherapy in ovarian "mature" teratoma.
Nishida T; Tazaki T; Oda T; Sugiyama T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Sep; 35(9):1658-60. PubMed ID: 6688628
[TBL] [Abstract][Full Text] [Related]
46. The Intergroup Rhabdomyosarcoma Study-I. A final report.
Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J
Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486
[TBL] [Abstract][Full Text] [Related]
47. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
48. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of malignant germ cell tumors of the ovary: a clinical analysis of 233 cases].
Zhang R; Hong W; Liu L
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):155-7. PubMed ID: 10920972
[TBL] [Abstract][Full Text] [Related]
50. Treatment of malignant ovarian germ cell tumors: response to vincristine, dactinomycin, and cyclophosphamide (preliminary report).
Slayton RE; Hreshchyshyn MM; Silverberg SC; Shingleton HM; Park RC; DiSalia PJ; Blessing JA
Cancer; 1978 Aug; 42(2):390-8. PubMed ID: 679144
[TBL] [Abstract][Full Text] [Related]
51. Management of malignant ovarian immature teratoma. Role of adriamycin.
Vergote IB; Abeler VM; Kjørstad KE; Tropé C
Cancer; 1990 Sep; 66(5):882-6. PubMed ID: 2201432
[TBL] [Abstract][Full Text] [Related]
52. Management of germ cell and stromal tumors of the ovary.
Slayton RE
Semin Oncol; 1984 Sep; 11(3):299-313. PubMed ID: 6091275
[No Abstract] [Full Text] [Related]
53. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
54. Long-term disease-free survival in immature teratoma of the ovary.
Dara P; Rich WM; Hodel K; DiSaia PJ
Cancer; 1982 Jul; 50(1):159-62. PubMed ID: 7083120
[No Abstract] [Full Text] [Related]
55. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
Williams SD; Blessing JA; Hatch KD; Homesley HD
J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
[TBL] [Abstract][Full Text] [Related]
56. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
Raghavan D; Levi J; Thomson D; Harvey V
Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
[No Abstract] [Full Text] [Related]
57. Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary.
Andersen WA; Young DE; Peters WA; Smith EB; Bagley CM; Taylor PT
Gynecol Oncol; 1989 Mar; 32(3):319-22. PubMed ID: 2537779
[TBL] [Abstract][Full Text] [Related]
58. Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: an update.
Willemse PH; Aalders JG; Bouma J; Mulder NH; Verschueren RC; de Vries EG; Sleijfer DT
Gynecol Oncol; 1987 Nov; 28(3):268-77. PubMed ID: 2445635
[TBL] [Abstract][Full Text] [Related]
59. Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).
Vriesendorp R; Aalders JG; Sleijfer DT; Willemse PH; Bouma J; Mulder NH
Cancer Treat Rep; 1984 May; 68(5):779-81. PubMed ID: 6202407
[TBL] [Abstract][Full Text] [Related]
60. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
Tiuliandin SA
Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
